STRS OHIO - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 93 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
STRS OHIO ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$200
-69.4%
12,000
-49.4%
0.00%
-66.7%
Q2 2023$654
-50.1%
23,700
-58.4%
0.00%
+50.0%
Q1 2023$1,310
+689.2%
57,000
+272.5%
0.00%
+100.0%
Q4 2022$166
-99.9%
15,3000.0%0.00%0.0%
Q3 2022$128,000
+5.8%
15,3000.0%0.00%0.0%
Q2 2022$121,000
-59.7%
15,300
+20.5%
0.00%0.0%
Q1 2022$300,000
-33.5%
12,700
-3.8%
0.00%
-50.0%
Q4 2021$451,000
+93.6%
13,2000.0%0.00%
+100.0%
Q3 2021$233,000
-40.9%
13,200
+50.0%
0.00%0.0%
Q2 2021$394,000
+52.1%
8,800
-12.0%
0.00%0.0%
Q1 2021$259,000
+28.9%
10,0000.0%0.00%0.0%
Q4 2020$201,000
-42.4%
10,000
-49.5%
0.00%
-50.0%
Q2 2020$349,000
+181.5%
19,800
+12.5%
0.00%
+100.0%
Q1 2020$124,0000.0%17,6000.0%0.00%0.0%
Q4 2019$124,000
+5.1%
17,600
+27.5%
0.00%0.0%
Q1 2018$118,000
+140.8%
13,800
+475.0%
0.00%
Q4 2017$49,000
+16.7%
2,4000.0%0.00%
Q3 2017$42,000
+55.6%
2,4000.0%0.00%
Q2 2017$27,000
-10.0%
2,4000.0%0.00%
Q1 2017$30,000
-42.3%
2,4000.0%0.00%
Q4 2016$52,000
+4.0%
2,4000.0%0.00%
Q3 2016$50,0002,4000.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$19,373,0004.95%
Bain Capital Life Sciences Investors, LLC 2,260,572$17,881,0002.10%
Finepoint Capital LP 735,126$5,815,0002.01%
Altium Capital Management LP 365,100$2,888,0001.16%
RTW INVESTMENTS, LP 4,794,499$37,924,0000.98%
Amitell Capital Pte Ltd 50,129$397,0000.90%
COWEN AND COMPANY, LLC 1,065,724$8,430,0000.81%
Tri Locum Partners LP 155,000$1,226,0000.50%
BVF INC/IL 1,106,838$8,755,0000.42%
HighVista Strategies LLC 46,459$367,0000.22%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders